Elite members get real-time data, technical charting, alerts, and no ads - starting at $24.96/mo.
Try Elite for Free
Index
RUT
Market Cap
879.52M
Enterprise Value
761.12M
Income
-40.88M
Sales
186.45M
Book/sh
8.77
Cash/sh
7.83
Dividend Est.
-
Dividend TTM
-
Dividend Ex-Date
-
Dividend Gr. 3/5Y
- -
Payout
-
Employees
738
IPO
Jan 31, 2005
P/E
-
Forward P/E
-
PEG
-
P/S
4.72
P/B
1.98
P/C
2.22
P/FCF
-
EV/EBITDA
-
EV/Sales
4.08
Quick Ratio
1.98
Current Ratio
2.08
Debt/Eq
0.47
LT Debt/Eq
0.09
Option/Short
Yes / Yes
EPS (ttm)
-0.82
EPS next Y
-0.65
EPS next Q
-0.18
EPS this Y
-156.31%
EPS next Y
18.06%
EPS next 5Y
-
EPS past 3/5Y
-0.23% 13.68%
Sales past 3/5Y
-9.45% 17.49%
EPS Y/Y TTM
17.42%
Sales Y/Y TTM
-8.01%
EPS Q/Q
24.23%
Sales Q/Q
7.74%
Insider Own
4.39%
Insider Trans
-10.34%
Inst Own
89.79%
Inst Trans
3.49%
ROA
-4.30%
ROE
-6.54%
ROIC
-6.17%
Gross Margin
40.16%
Oper. Margin
-21.25%
Profit Margin
-21.92%
SMA20
0.11%
SMA50
3.92%
SMA200
32.41%
Trades
Shs Outstand
50.65M
Shs Float
48.43M
52W High
18.73 -7.29%
52W Low
7.61 128.19%
Volatility
4.56% 3.92%
ATR (14)
0.70
RSI (14)
52.16
Beta
1.90
Rel Volume
0.52
Avg Volume
636.62K
Volume
23,171
Perf Week
3.12%
Perf Month
-0.20%
Perf Quarter
14.62%
Perf Half Y
63.98%
Perf YTD
80.89%
Perf Year
63.36%
Perf 3Y
71.59%
Perf 5Y
-77.63%
Perf 10Y
848.91%
Prev Close
17.83
Price
17.36
Change %
-2.61%
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
SHELTON JERRELLPresident, CEOAug 11 '26Sale14.9128,800429,3851,201,814Aug 11 06:49 PM
JERRELL W SHELTONDirectorAug 11 '26Proposed Sale14.8228,800426,816Aug 11 04:31 PM
ZECCHINI EDWARD JChief Digital and Tech OfficerJun 11 '26Option Exercise4.8033,600161,280143,319Jun 12 06:38 PM
ZECCHINI EDWARD JChief Digital and Tech OfficerJun 10 '26Option Exercise4.801,4006,720111,119Jun 12 06:38 PM
ZECCHINI EDWARD JChief Digital and Tech OfficerJun 11 '26Sale14.4733,600486,239109,719Jun 12 06:38 PM
ZECCHINI EDWARD JChief Digital and Tech OfficerJun 10 '26Sale15.231,40021,324109,719Jun 12 06:38 PM
EDWARD ZECCHINIOfficerJun 11 '26Proposed Sale14.4733,600486,239Jun 11 04:09 PM
EDWARD ZECCHINIOfficerJun 10 '26Proposed Sale15.231,40021,324Jun 10 04:15 PM
STEFANOVICH ROBERTChief Financial OfficerJun 04 '26Sale16.27169,4272,756,984109,850Jun 08 09:11 PM
Mandalam RamkumarDirectorJun 08 '26Sale15.4423,214358,45267,894Jun 08 09:05 PM
RAMKUMAR MANDALAMDirectorJun 08 '26Proposed Sale15.4423,214358,452Jun 08 04:17 PM
STEFANOVICH ROBERTOfficerJun 04 '26Proposed Sale16.50169,4272,795,546Jun 03 04:35 PM
SHELTON JERRELLPresident, CEOApr 21 '26Option Exercise1.87104,007194,4931,230,614Apr 23 08:00 PM
SHELTON JERRELLPresident, CEOApr 06 '26Option Exercise1.8750,00093,5001,126,607Apr 08 06:32 PM
STEFANOVICH ROBERTChief Financial OfficerMar 23 '26Sale8.181,0948,949279,277Mar 25 08:01 PM
SHELTON JERRELLPresident, CEOMar 23 '26Option Exercise1.8725,00046,7501,076,607Mar 25 08:00 PM
SHELTON JERRELLPresident, CEOMar 23 '26Sale8.182,89423,6731,051,607Mar 25 08:00 PM
Sawicki Mark WChief Scientific OfficerMar 23 '26Sale8.181,34110,969102,356Mar 25 08:00 PM
ZECCHINI EDWARD JSee RemarksMar 16 '26Sale8.002,01416,112109,719Mar 17 08:01 PM
SHELTON JERRELLPresident, CEOMar 16 '26Sale8.007,91863,3441,054,501Mar 17 08:00 PM
Sawicki Mark WChief Scientific OfficerMar 16 '26Sale8.003,23525,880103,697Mar 17 08:00 PM
STEFANOVICH ROBERTChief Financial OfficerMar 12 '26Option Exercise1.8787,188163,042294,401Mar 16 09:35 PM
STEFANOVICH ROBERTChief Financial OfficerMar 12 '26Sale7.7638,700300,386255,701Mar 16 09:35 PM
STEFANOVICH ROBERTChief Financial OfficerMar 16 '26Sale8.002,74321,944280,371Mar 16 09:35 PM
ROBERT S. STEFANOVICHOfficerMar 12 '26Proposed Sale7.7638,700300,386Mar 12 04:17 PM
Mandalam RamkumarDirectorDec 10 '25Sale9.9911,570115,54080,758Dec 12 05:30 PM
RAMKUMAR MANDALAMDirectorDec 10 '25Proposed Sale9.9911,570115,540Dec 10 04:10 PM
Cryoport, Inc. engages in the provision of logistics solutions to the life science industry. It also provides logistics solutions for biologic materials such as immunotherapies, stem cells, CAR-T cells, and reproductive cells for clients worldwide, including points-of-care, clinical research organizations central laboratories, biopharmaceuticals, contract manufacturing, health centers, and university researchers. It offers personalized medicine, immunotherapies, cellular therapies, CAR T-cell therapies, stem cell therapies, vaccines, diagnostic materials, semen, eggs, embryos, cord blood, bio-pharmaceuticals, infectious substances, and other commodities that require continuous exposure to certain ranges of precision-controlled temperatures. The company was founded on May 25, 1990 and is headquartered in Brentwood, TN.
ChairmanMr. Jerrell W. Shelton
Senior VPMr. Robert S. Stefanovich MS
Senior VP and Chief Digital & Technology OfficerMr. Edward J. Zecchini
Senior VP & Chief Scientific OfficerDr. Mark W. Sawicki Ph.D.
Vice President of Corporate Development & Investor RelationsMr. Thomas J. Heinzen